Fearful of swine fever, France plans fence on Belgian border
STRASBOURG, France (Reuters) – France will start putting up fencing along part of its border...
Read More
Updated
U.S. appeals court upholds ruling that canceled Teva Copaxone patents
By Jan Wolfe (Reuters) – A U.S. appeals court on Friday upheld a ruling that canceled patents owned by Teva Pharmaceutical Industries Ltd on its blockbuster multiple sclerosis drug Copaxone. The ruling was a victory for a...
Read More
South Africa’s Tiger Brands re-opens processing facility after listeria outbreak
JOHANNESBURG (Reuters) – Tiger Brands said on Friday it had re-opened a facility that was...
Read More
Abbvie settles Humira patent disputes with Novartis unit
(Reuters) – Abbvie Inc said on Thursday it settled all patent disputes with Novartis AG,...
Read More
Jury clears J&J of liability in New Jersey talc cancer case
By Tina Bellon (Reuters) – A New Jersey jury on Thursday cleared Johnson & Johnson of...
Read More
Bristol-Myers’ Opdivo fails to meet lung cancer study goal
(Reuters) – Bristol-Myers Squibb Co said on Friday that its blockbuster cancer drug Opdivo...
Read MoreChina agriculture ministry says 72 pigs dead in new African swine fever outbreak
BEIJING (Reuters) – China’s agriculture ministry said on Friday that 72 pigs had died in another outbreak of African swine fever in the country’s northeastern province of Liaoning, the fourth reported in the...
Read More
Malaria mosquitoes wiped out in lab trials of gene drive technique
By Kate Kelland LONDON (Reuters) – Scientists have succeeded in wiping out a population of...
Read More
Medtronic disables pacemaker programmer updates over hack concern
By Jim Finkle NEW YORK (Reuters) – Medical device maker Medtronic Plc has disabled internet...
Read More
WHO sees Congo’s Ebola outbreak lasting 3-4 months at least
By Tom Miles GENEVA (Reuters) – Democratic Republic of Congo’s Ebola outbreak is...
Read More
Bristol-Myers to invest in Compugen, collaborate in clinical trials
TEL AVIV (Reuters) – Bristol-Myers Squibb Co and Israel’s Compugen said on Thursday...
Read MoreAcelRx shares surge after FDA staff says opioid safe
(Reuters) – AcelRx Pharmaceuticals Inc’s shares surged 30 percent on Wednesday after U.S. Food and Administration staff said the company’s opioid treatment was safe and effective, bringing it one step closer to...
Read MoreLGBT youth at higher risk for suicide attempts
(This October 8 story has been refilled to correct “transsexual” to “transgender” in paragraph 3) By Linda Carroll (Reuters Health) – LGBT adolescents are more likely than other kids their age to...
Read More
U.S. FDA panel backs Celltrion copycat of Roche blood cancer drug
(Reuters) – Celltrion Pharm Inc’s biosimilar of Roche Holding AG’s blockbuster...
Read More
FDA halts imports from China’s Huahai Chuannan plant
(This 28 September story has been refilled as FDA spokesman corrects information to show import...
Read More
J&J’s Stelara succeeds in chronic bowel disease study
(Reuters) – Johnson & Johnson said on Tuesday its blockbuster drug Stelara was found to...
Read MoreFDA staff raises safety issues over Trevena opioid injection
(Reuters) – Trevena Inc’s opioid injection to treat acute pain could be abused and potentially lead to overdose, staff reviewers of the U.S. Food and Drug Administration said on Tuesday, sending the drugmaker’s...
Read MoreChina says efforts to control African swine fever outbreak in pivotal phase
BEIJING (Reuters) – China’s agriculture ministry said on Tuesday that the country’s African swine fever outbreak remains complex and severe, and prevention and control efforts are in a pivotal period. China has...
Read More
China bans pig imports from Japan, Belgium over swine fever
BEIJING (Reuters) – China banned imports of pigs, wild boars and products from Belgium after...
Read MoreBausch Health’s plaque psoriasis lotion gets tentative FDA approval
By Saumya Joseph (Reuters) – Bausch Health Cos Inc, formerly Valeant Pharmaceuticals, said on Monday it received tentative U.S. approval to market its plaque psoriasis lotion, Bryhali. The company plans to launch the...
Read More